BioCalifornia is a coalition of innovators, investors, and industry leaders gathered under the auspices of the California Technology Council. Its members are committed to the growth of life sciences, and commercialization of discoveries to improve human health, the environment, and sustainability; and capitalizing on the convergence of biology with information technology. BioCalifornia works with its members to explore topics on the frontiers of innovation, creates opportunities for business development and investment, and showcases the expertise resident both within its members and other CTC special interest groups, such as CalCISO, Clean Acres, and the California Business Incubation Alliance.

Who is BioCalifornia? To advise and steer this initiative, a BioCalifornia Advisory Board has been formed. The BioCalifornia Advisory Board includes these representatives:

  • Kinkead Reiling, Angel Investor
  • Antoinette Konski, Partner, Foley & Lardner
  • Ahmed Enany, CEO, Southern California Biomedical Council
  • Evan Siegel, CEO, GroundZero Pharmaceuticals
  • Paul Zorner, President, Locus Agricultural Solutions
  • Andy Jane, Managing Director, Talu Ventures
  • Michael Shuster, Partner, Fenwick & West
  • Steve Abbott, Co-founder and CEO, Sensory Innovations
  • Daniel Levine, Principal, Levine Media Group
  • Ed Amento, CEO, Molecular Medicine Research Institute
  • H. Daniel Perez, Chairman and CEO, Naia Pharma


First Pitch: Wearables + Digital Health, Los Angeles, November 8

Cyber Summit: Cybersecurity in Health + Life Sciences, Bay Area, November 16


BioCalifornia Insights Series, Novel Approaches in Neuroscience, September 21 in Palo Alto

BioCalifornia Insights Series, August 17 in San Francisco

BioCalifornia Insights Series, July 20 in Palo Alto

OpenIDEO Design Think: Combating Future Health Threats, June 7 in San Francisco

BioCalifornia Welcome Reception, June 9 in San Francisco